Navigation Links
New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
Date:5/22/2013

rs or deflection devices should be incorporated into the procedures to protect the brain from ischemic insults
  • DEFLECT-I results demonstrate great promise and value of cerebral protection
  • Dr Jeffrey Moses , MD, Columbia University, NY

    "The issue of stroke is one of the key areas of development for enhancing procedural safety in TAVR and other invasive treatments in cardiology. The preliminary data from the TriGuard MRI study points to this technology as a potential solution to this important issue"

    The TriGuard Cerebral Protection Device is an investigational device and not commercially available.

    About KeystoneHeart
    Keystone Heart Ltd is a medical device company developing and manufacturing cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain damage associated with cardiovascular procedures. The Company is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures. Novel devices are designed to help interventional cardiologists, electrophysiologists and cardiac surgeons to preserve brain reserve while performing these procedures.

    Keystone Heart is dedicated to advancing patient care through innovative technology and clinical research. Clinical studies with the TriGuard™ Cerebral Protection Device (TAVR procedures) are currently ongoing in Europe, Canada and Brazil with impending CE Mark.

    Keystone Heart collaborates with renowned interventional cardiologists, cardiac surgeons and neurologists.

    The Company's management has extensive experience in the fields of interventional cardiology and medical devices.

    Founded in 2004 an
    '/>"/>

    SOURCE Keystone Heart
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
    2. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
    3. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
    4. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
    5. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
    6. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
    7. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
    8. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
    9. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    10. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
    11. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... personalized immune therapies for operable and inoperable solid tumor cancers, ... at the 7 th Annual Phacilitate Immunotherapy Forum in ... presentation at Phacilitate will take place on January 26 at ...
    (Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
    (Date:1/23/2015)... Fla. , Jan. 23, 2015  iMD Companies, Inc. (ICBU) ... to increase market share and grab a foothold in the ... influence, production capabilities and a presence in the sector, and ... facilitate the growth of hemp and medical marijuana, iMD is ...
    Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
    ... N.C., June 30, 2011 AAIPharma Services Corp., a ... announced that it has passed inspection of its Durham ... with no inspectional observations. The May 2011 audit is ... have not been issued an FDA-483 citing any inspection ...
    ... 2011 Metamark Genetics, a privately-held oncology molecular ... Intelligence™ company, today announced a development and commercialization ... multiplex protein detection platform with image analysis technology ... and predictive assays for early-stage cancers. ...
    Cached Medicine Technology:AAIPharma Services Builds Compliance Record at Lab, Manufacturing and Packaging Operations 2Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics 2Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics 3
    (Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
    (Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
    (Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
    (Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
    (Date:1/22/2015)... has released a new blog post explaining the importance of keeping ... costs of an auto insurance policy . , Clients who ... for their vehicle insurance policies. The safety a vehicle offers from ... Because of this, drivers should always carry a first aid kit ...
    Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
    ... Well Woman Centre of Ireland has warned that outsourcing ... some patients. It could also lead to lead to inconsistencies ... ,The Well Woman Centre has criticized the Health ... US, as it could have serious ramifications for women with ...
    ... PET-CT scanners with standard commercial software designed to provide ... disease in as many as 40 percent of patients ... professor in the Division of Cardiology at The University ... the abnormalities upon his initial use of cardiac PET-CT ...
    ... the development and commercialization of proprietary pharmaceuticals for ... , today announced that under the Special Protocol ... the United States Food and Drug Administration (FDA) ... for crofelemer for the treatment of chronic diarrhea ...
    ... the rage today in advanced countries. But consumers seeking ... questions before they decide to go in for ... functional foods market is a $40 billion industry. ... lower bad cholesterol (LDL). ,* Probiotic yoghurts ...
    ... the University of Southern California have applied a nanoscale ... up an old puzzle of the global carbon and ... advanced online publication of The ISME Journal. ... nanometer-scale, secondary ion mass spectrometry) located at Lawrence Livermore ...
    ... get hookah smoking exempted from Englands smoking ban for ... health effects , doctors writing in this weeks BMJ ... ,A hookah is a glass based waterpipe used for ... smoking herbal fruits after meals, but it is becoming ...
    Cached Medicine News:Health News:Irish Outsourcing of Smear Test may Result in Cervical Cancer Being Undetected 2Health News:Inaccuracies in Cardiac PET-CT Scanning 2Health News:Inaccuracies in Cardiac PET-CT Scanning 3Health News:Napo Obtains Special Protocol Assessment Agreement From FDA for Crofelemer 2Health News:Functional Food What is That, Ask First 2Health News:Functional Food What is That, Ask First 3Health News:Nanospectrometer Aids in Identifying Nutrient Cycle 2Health News:Ban on Hookah Smoking Should Stay, Argue Doctors 2
    ... The Minimally Invasive Hip Instruments ... THA through a mini-incision using ... set of instruments helps reduce ... invasive THA by optimizing exposure ...
    The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
    Instrument set for carpal tunnel release....
    Standard arthroscopy graspers for small joints. Also available are Mosquito Tip Graspers, 45 degree Forceps, SquareTrimmer Blunt Tip Forceps and SST Scoop Tip Forceps....
    Medicine Products: